BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21344771)

  • 1. [Significance of application of immunocytochemical detection of GD2 antigen in bone marrow in neuroblastoma patients].
    Bolek-Marzec K; Balwierz W; Wieczorek A; Szewczyk K
    Przegl Lek; 2010; 67(6):409-12. PubMed ID: 21344771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
    Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
    N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow.
    Méhes G; Luegmayr A; Ambros IM; Ladenstein R; Ambros PF
    Clin Cancer Res; 2001 Jul; 7(7):1969-75. PubMed ID: 11448912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases.
    Schumacher-Kuckelkorn R; Hero B; Ernestus K; Berthold F
    Pediatr Blood Cancer; 2005 Aug; 45(2):195-201. PubMed ID: 15800908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The significance of immunological analysis for the detection of residual neuroblasts in bone marrow].
    Maritaz O; Combaret V; Favrot MC
    Pathol Biol (Paris); 1988 Jan; 36(1):21-4. PubMed ID: 3283668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
    Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
    Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE.
    Cheung IY; Cheung NK
    Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The TH, ELAVL4 and GD2 gene expression as diagnostic markers of bone marrow lesions in patients with neuroblastoma].
    Druĭ AE; Tsaur GA; Popov AM; Tuponogov SN; Shorikov EV; Tsvirenko SV; Savel'ev LI; Fechina LG
    Vopr Onkol; 2012; 58(4):514-20. PubMed ID: 23607207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The identification of minimal residual disease in the bone marrow and peripheral blood in neuroblastoma. The prognostic and therapeutic implications].
    Faulkner LB; Tamburini A; Tintori V; Paoli A; Tondo A; Bernini G; Medicina D; Brisigotti M; Corrias MV; Scaruffi P; Rosanda C; Lo Piccolo MS; Viscardi E; Milanaccio C; Garaventa A; De Bernardi B
    Pediatr Med Chir; 1998; 20(3):175-8. PubMed ID: 9744008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
    Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
    Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.
    Cheung IY; Barber D; Cheung NK
    Clin Cancer Res; 1998 Nov; 4(11):2801-5. PubMed ID: 9829745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disialoganglioside directed immunotherapy of neuroblastoma.
    Modak S; Cheung NK
    Cancer Invest; 2007 Feb; 25(1):67-77. PubMed ID: 17364560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of minimal residual disease in children with neuroblastoma].
    De Moerloose B; Swerts K
    Verh K Acad Geneeskd Belg; 2005; 67(1):33-44. PubMed ID: 15828305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of disialoganglioside GD2-antigen and binding of anti-GD2 antibodies on spheroids of neuroblastoma cell line.
    Heiss P; Bermatz S; Wehnes H; Heinzmann U; Senekowitsch-Schmidtke R
    Anticancer Res; 1997; 17(4B):3145-7. PubMed ID: 9329622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early molecular response of marrow disease to biologic therapy is highly prognostic in neuroblastoma.
    Cheung IY; Lo Piccolo MS; Kushner BH; Cheung NK
    J Clin Oncol; 2003 Oct; 21(20):3853-8. PubMed ID: 14551304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.
    Cheung NK; Von Hoff DD; Strandjord SE; Coccia PF
    J Clin Oncol; 1986 Mar; 4(3):363-9. PubMed ID: 3081691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry.
    Bozzi F; Gambirasio F; Luksch R; Collini P; Brando B; Fossati-Bellani F
    Anticancer Res; 2006; 26(5A):3281-7. PubMed ID: 17094441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
    Thorban S; Roder JD; Pantel K; Siewert JR
    Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.